SEC Form 4 research
| Issuer | UroGen Pharma Ltd. |
|---|---|
| Tickers | URGN |
| Reporting owners | 23 |
| Officers and directors | 7 |
| Last public filing | 2026-10-09 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-09 | 2026-10-08 | Degnan Chris | S | 2,202 | $36.69 | Not reported |
| 2026-09-09 | 2026-09-08 | Schoenberg Mark | S | 871 | $42.92 | Not reported |
| 2026-09-09 | 2026-09-08 | Smith Jason Drew | S | 1,519 | $42.54 | Not reported |
| 2026-08-24 | 2026-08-20 | Schoenberg Mark | S | 60,677 | $47.05 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.